Background: Many patients with coronary heart disease (CHD) are not managed adequately, and we often fail to reach treatment targets. Aim: To investigate if knowledge of risk factors for CHD, measured by a questionnaire, would show any relation to advice to compliance to lifestyle changes to attain treatment goals and adherence to drug therapy. Method: Men and women <71 years who had had a cardiac event were screened consecutively (509) from the medical records. Responders (392) were interviewed, examined and received a questionnaire. Three hundred and forty-seven patients answered the questionnaire regarding their general knowledge of risk factors for CHD, compliance to lifestyle changes to attain treatment goals and adherence to drug therapy. Results: There were statistically significant correlations between general knowledge about risk factors for CHD and compliance to certain lifestyle changes: weight, physical activity, stress management, diet, attainment of lipid level goals and the likelihood of taking prescribed blood pressure-lowering drugs. General knowledge of risk factors had no correlation to blood glucose or blood pressure levels nor on smoking habits or treatment patterns for prescribed lipid- and blood glucose-lowering drugs. Conclusion: Knowledge correlates to patient behaviour with respect to some risk factors, which should be recognised in preventive programs.
KannelW.B.WilsonP.W.An update on coronary risk factorsMed. Clin. N. Am791995951–971
3.
MannienV.EloM.O.FrickM.H.HaapaK.HeinonenO.P.HeinsalmiP.Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart StudyJ. Am. Med. Assoc26051988641–651
4.
PedersenT.R.OlssonA.G.FaergemanO.KjekshusJ.WedelH.BergK.Lipoprotein changes and reduction in the incidence of major coronary heart disease in the Scandinavian Simvastatin Survival Study (4S)Circulation971519981453–1460
5.
WoodD.de BackerG.FaergemanO.GrahamI.ManciaG.PyöräläK.Members of the task force. Prevention of coronary heart disease in clinical practice. Recommendation of the Second Joint Task Force of European and other societies on coronary preventionEur. Heart J191019981434–1503
6.
NestroR.W.ZarichS.Acute myocardial infarction in diabetes mellitus. Lessons learned from ACE inhibitionCirculation97199812–15
7.
8.
HaynesR.B.SackettD.L.GibsonE.S.TaylorD.W.HackettB.C.RobertsR.S.Improvement of medication compliance in uncontrolled hypertensionLancet19761265–1268
9.
BeckerM.H.Understanding patients complianceCohenS.J.New direction in patient compliance1978Lexington BooksLexington, MA1–31
10.
EUROASPIREA European Society of Cardiology survey of secondary prevention of coronary heart disease principal results. EUROASPIRE Study groupEur. Heart J1819971569–1582
11.
EUROASPIRE II Study GroupLifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II. Euro Heart Survey ProgrammeEur. Heart J222001554–572
12.
CampellN.C.ThainJ.DeansH.G.RitchieL.D.RawlesJ.M.Secondary prevention in coronary heart disease: baseline survey of provision in general practiceBr. Med. J316719981430–1434
13.
PearsonT.A.LauroraI.ChuH.KafonekS.The Lipid treatment Assessment Project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemi patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goalsArch. Intern. Med1602000459–467
14.
HarnickD.J.CohenJ.L.SchechterC.B.FusterV.SmithD.A.Effects of practice setting on quality of lipid-lowering management in patients with coronary artery diseaseAm. J. Cardiol811219981416–1420
15.
16.
17.
18.
19.
European Diabetes Policy GroupA desktop guide to Type 2 diabetes mellitusDiabet. Med161999716–730
20.
The expert committee on the diagnosis and classification of diabetes mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitusDiabetes Care2019971183–1197
21.
BondW.S.HussarD.A.Detection methods and strategies for improving medication complianceAmerican Society of Hospital Pharmacist4819911978–1987
22.
HamiltonR.A.BrieclandL.L.Use of prescription-refill records to assess patient complianceAm. J. Hosp. Pharm4919921691–1696
23.
24.
HuskissonE.C.Measurement of painLancetii19741127–1131
25.
AitkenR.C.B.A growing edge of measurement of feelingsProc. R. Soc. Med621969989–992
26.
ScottP.J.HuskissonE.C.Measurement of functional capacity with visual analogue scalesRheumatol. Rehabil161978257–259
27.
ScottP.J.HuskissonE.C.Accuracy of subjective measurements made with and without previous scores: an important source of error in serial measurement of subjective statesAnn. Rheum. Dis381979558–559
28.
LickertR.A.A technique for the development of attitudes scalesEduc. Psychol. Meas121952313–315
29.
30.
MillerG.A.The magic number seven plus or minus two: some limits on our capacity for processing informationPsychol. Bull63195681–97
31.
SvenssonE.Construction of a single global scale for multi-item assessments of the same variableStat. Med2020013831–3846
32.
ShepardJ.AlcaldeV.BefortP.-A.BoucherB.ErdmannE.GutzwillerG.International comparison of awareness and attitudes towards coronary risk factor reduction: the HELP studyJ. Cardiovasc. Risk41997373–384
33.
34.
LeyP.SpelmanM.S.Communications in an out-patient settingBr. J. Soc. Clin. Psychol41965114–116
35.
TeeceJ.J.Relationship of anxiety (drive) and response competition in problem solvingJ. Abnorm. Soc. Psychol701965465–467
36.
O'ConnellJ.K.PriceJ.H.Health locus of control of physical fitness-program participantsPercept. Mot. Skills551982925–926
37.
38.
WallstonK.A.MaidesS.WallstonB.S.Health-related information seeking as a function of health-related locus of control and health valueJ. Res. Pers101976215–222
39.
WallstonK.A.WallstonB.S.Health locus of control scalesLefcourtH.M.Research with the locus of control construct1981Academic PressNew York189–243
40.
41.
FinlaysonA.Social networks as coping resources: lay help and consultation patterns used by women in husband” post-infarction careerSoc. Sci. Med10197697–103
42.
SiegristJ.DittmanK.RottnerK.WeberI.The social context of active distress in patients with early myocardial infarctionSoc. Sci. Med161982443–453
43.
StrömbergA.BroströmA.DahlströmU.FridlundB.Factors influencing patient compliance with therapeutic regimens in chronic heart failure: a critical incident technique analysisHeart Lung281999334–341
44.
WeinbergerD.A.SchwartzG.E.DavidsonJ.R.Low anxious, high anxious, and depressive coping styles: psychometric patterns and behavioural physiological responses to stressJ. Abnorm. Psychology881979369–380
45.
ShawR.E.CohenF.DoyleB.PaleskyJ.The impact of denial and repressive style on information gain and rehabilitation outcomes in myocardial infarction patientsPsychosom. Med471985262–273
46.
DiMatteoM.R.Enhancing patients adherence to medical recommendationsJ. Am. Med. Assoc271199479–83
47.
DonovanJ.L.Patient decision making. The missing ingredient in compliance researchInt. J. Technol. Assess. Health Care1131995443–455
48.
ErhardtL.Are we treating to target?Atherosclerosis. Supplement120009–14
49.
ErhardtL.R.The essence of effective treatment and compliance is simplicityAm. J. Hypertens121999105S–110S
50.
DeccacheA.AujoulatI.A European perspective: common developments, differences and challenges in patient educationPatient Education and Counseling4420017–14
